US20100063577A1 - Method of implanting a prosthetic valve - Google Patents

Method of implanting a prosthetic valve Download PDF

Info

Publication number
US20100063577A1
US20100063577A1 US12/621,214 US62121409A US2010063577A1 US 20100063577 A1 US20100063577 A1 US 20100063577A1 US 62121409 A US62121409 A US 62121409A US 2010063577 A1 US2010063577 A1 US 2010063577A1
Authority
US
United States
Prior art keywords
frame member
body vessel
graft
expandable
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/621,214
Inventor
Brian C. Case
Thomas A. Osborne
Jacob A. Flagle
Fred T. Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Inc
Original Assignee
Cook Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Inc filed Critical Cook Inc
Priority to US12/621,214 priority Critical patent/US20100063577A1/en
Publication of US20100063577A1 publication Critical patent/US20100063577A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2475Venous valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/0078Quadric-shaped hyperboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts

Definitions

  • the invention relates to implantable medical devices. More specifically, the invention relates to prosthetic valves for implantation in a body vessel.
  • venous valves While natural valves may function for an extended time, some may lose effectiveness, which can lead to physical manifestations and pathology. For example, venous valves are susceptible to becoming insufficient due to one or more of a variety of factors. Over time, the vessel wall may stretch, affecting the ability of the leaflets to close. Furthermore, the natural valve leaflets may become damaged, such as by formation of thrombus and scar tissue, which may also affect the ability of the valve leaflets to close. Once a valve is damaged, venous valve insufficiency may be present, and can lead to discomfort and possibly ulcers in the legs and ankles.
  • venous valve insufficiency treatments for venous valve insufficiency include the use of compression stockings that are placed around the leg of a patient. Surgical techniques are also employed in which valves can be bypassed, removed, or replaced with autologous sections of veins that include competent valves.
  • Minimally invasive techniques and instruments for placement of intralumenal medical devices have developed over recent years.
  • a wide variety of treatment devices that utilize minimally invasive technology has been developed and includes stents, stent grafts, occlusion devices, infusion catheters and the like.
  • Minimally invasive intravascular devices have especially become popular with the introduction of coronary stents in the U.S. market in the early 1990's.
  • Coronary and peripheral stents have been proven to provide a superior means of maintaining vessel patency, and have become widely accepted in the medical community.
  • the use of stents has been extended to treat aneurisms and to provide occlusion devices, among other uses.
  • prosthetic valves have been developed that include a support frame such as a stent.
  • a graft member can be attached to the support frame to provide a valve function to the device.
  • the graft member can be in the form of a leaflet that is attached to a stent and movable between first and second positions. In a first position, the valve is open and allows fluid flow to proceed through a vessel in a first direction, and in a second position the valve is closed to prevent fluid flow in a second, opposite direction.
  • An example of this type of prosthetic valve is described in commonly owned U.S. Pat. No.
  • Medical devices for implantation in a body vessel.
  • Medical devices comprise first and second frame members and a graft member forming a valve that permits fluid flow through a body vessel in a first direction, and substantially prevents fluid flow through the body vessel in a second, opposite direction At least a portion of the graft member is disposed between the frame members.
  • a prosthetic valve in one exemplary embodiment, comprises first and second tubular frame members and a graft member disposed between the frame members.
  • the second tubular frame member is circumferentially disposed around the first tubular frame member.
  • the graft member forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • a prosthetic valve in another exemplary embodiment, comprises first and second tubular frame members and a graft member disposed between the frame members.
  • the first tubular frame member defines axially-extending extension points and the second tubular frame member is circumferentially disposed around the first tubular frame member.
  • the graft member is attached to the extension points of the first tubular frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • a prosthetic valve in another exemplary embodiment, comprises first and second tubular frame members and a tubular graft member.
  • the first tubular frame member defines first and second axially-extending extension points
  • the second tubular frame member is circumferentially disposed around the first tubular frame member.
  • the second tubular frame member defines a sinus portion.
  • the graft member has a first portion disposed on an external surface of the second tubular frame member, and a second portion disposed between the first and second tubular frame members. The second portion is attached to the extension points of the first tubular frame member, and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in second, opposite direction.
  • a prosthetic valve according to the invention comprises first and second frame members and a graft member.
  • ends of the frame members overlap and a portion of the graft member is disposed between the overlapping ends.
  • Another portion of the graft member is disposed radially inward of another end of the second frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • a prosthetic valve in another exemplary embodiment, comprises first and second tubular frame members and a tubular graft member. An end of the second tubular frame member is disposed circumferentially around an end of the first tubular frame member to form an overlap region. A portion of the tubular graft member is disposed on a portion of an external surface of the first tubular frame member and another portion of the tubular graft member is disposed between the first and second tubular frame members at the overlap region. A third portion of the graft member is attached to a portion of the internal surface of the second tubular frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • the invention also provides methods of making prosthetic valves for implantation in a body vessel.
  • One method according to the invention comprises providing a first frame member, providing a second frame member, providing a graft member, disposing at least a portion of the graft member between the first and second frame members, and forming a valve with the graft member.
  • the invention also provides methods of implanting a prosthetic valve in a body vessel.
  • One method according to the invention comprises providing a prosthetic valve comprising first and second frame members and a graft member disposed between the first and second frame members and forming a valve; percutaneously delivering the prosthetic valve through a body vessel to a point of treatment; and deploying the prosthetic valve at the point of treatment.
  • Another method of implanting a prosthetic valve comprises providing a first frame member; providing a second frame member with an attached graft member that forms a valve; percutaneously delivering the first frame member through a body vessel to a point of treatment; deploying the first frame member at the point of treatment; percutaneously delivering the second frame member to the point of treatment; and deploying the second frame member.
  • FIG. 1 is a perspective view, partially broken away, of a prosthetic valve according to a first exemplary embodiment of the invention.
  • FIG. 2 is a cross-sectional view of the prosthetic valve illustrated in FIG. 1 , taken along line 2 - 2 .
  • FIG. 3 is a magnified view of area 3 in FIG. 2 .
  • FIG. 4 is a magnified view of a prosthetic valve according to an alternative embodiment of the invention.
  • FIG. 5 is a perspective view, partially broken away, of a prosthetic valve according to a second exemplary embodiment of the invention.
  • FIG. 6 is a perspective view, partially broken away, of a prosthetic valve according to a third exemplary embodiment of the invention.
  • FIG. 7 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 8 is a perspective view, partially broken away, of a prosthetic valve according to a fourth exemplary embodiment of the invention that incorporates the frame member illustrated in FIG. 7 .
  • FIG. 9 is a perspective view, partially broken away, of the prosthetic valve illustrated in FIG. 8 with the valve in a closed configuration.
  • FIG. 10 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 11 is a perspective view of the frame member illustrated in FIG. 10 with an attached graft member.
  • FIG. 12 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 13 is a perspective view of the frame member illustrated in FIG. 12 with an attached graft member.
  • FIG. 14 is a perspective view of a prosthetic valve according to a fifth exemplary embodiment of the invention.
  • FIG. 15 is a magnified view of area 15 in FIG. 14 .
  • FIG. 16 is a perspective view of the prosthetic valve illustrated in FIG. 14 with the valve in a closed configuration.
  • FIG. 17 is a perspective view of a prosthetic valve according to a sixth exemplary embodiment of the invention.
  • FIG. 18 is a magnified view of area 18 in FIG. 17 .
  • FIG. 19 is a block diagram of a method of making a prosthetic valve according to the invention.
  • FIG. 20 is a block diagram of a method of implanting a prosthetic valve according to the invention.
  • FIG. 21 is a block diagram of a method of implanting a prosthetic valve according to the invention.
  • the invention provides prosthetic valves for use in a body vessel, such as the human vasculature.
  • Prosthetic valves according to the invention comprise first and second frame members and a graft member forming a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction. At least a portion of the graft member is disposed between the frame members.
  • the inclusion of two frame members in the prosthetic valves of the invention is expected to provide a stable structure for the valves under typical loads for a particular application. Also, it is believed that the inclusion of two frame members will provide a separation between one or more portions of the graft member and an interior wall of a body vessel in which the prosthetic valve is implanted. This separation may protect portions, such as valve leaflets, of graft members formed of certain materials, such as extracellular matrix (ECM) materials, from incorporation into the vessel wall.
  • ECM extracellular matrix
  • Medical devices according to the invention can be used as a valve in a variety of body vessels, including within the heart, digestive tract, and other body vessels. Exemplary embodiments of the invention are particularly well suited for use as percutaneously delivered prosthetic venous valves.
  • FIGS. 1 through 3 illustrate a prosthetic valve 10 according to a first exemplary embodiment of the invention.
  • the prosthetic valve 10 comprises a first frame member 12 , a second frame member 14 , and a graft member 16 partially disposed between the first 12 and second 14 frame members.
  • the second frame member 14 is disposed radially outward from the first frame member 12 . That is, the second frame member 14 intersects a hypothetical radial line 13 extending from a hypothetical central point 15 and through the frame members 12 , 14 at a point further from the central point 15 than a point at which the first frame member 12 intersects the line 13 .
  • first 12 and second 14 frame members comprise tubular members, and the first frame member 12 is disposed within a lumen defined by the second frame member 14 .
  • the second frame member 14 is disposed circumferentially around the first frame member 12 .
  • the first 12 and second 14 frame members have substantially the same axial lengths.
  • the first 12 and second 14 frame members comprise structural bodies having one or more surfaces.
  • the first frame member 12 has an exterior surface 30 that can include an adhesive 32 or other means for attaching the graft member 16 to the frame member 12 .
  • Any suitable means for attaching two members can be used, and specific, non-limiting examples include sutures, clips, metal and plastic bands, barbs, weld joints, and other attachment elements.
  • the second frame member 14 has an interior surface 34 that may also include an adhesive or other means for attaching (not illustrated in FIGS. 1 through 3 ) the graft member 16 to the second frame member 14 .
  • Each of the frame members 12 , 14 can comprise any suitable frame that provides the desired surfaces between which a portion of the graft member 16 can be disposed. As best illustrated in FIGS. 1 and 2 , each frame member 12 , 14 can comprise a tubular frame member. Medical stents provide tubular frame members, and any suitable medical stent can be used in the prosthetic valves of the invention. It is noted, though, that the frame member(s) need not provide a stenting function; such a function is optional.
  • the stent can be any suitable type of stent, including a wire frame member, a solid tubular member, a tubular member with openings cut therein, or any other suitable medical stent.
  • suitable stents for use in the prosthetic valves of the invention include the stents described in U.S. Pat. Nos. 6,508,833 to Pavcnik et al. for a MULTIPLE-SIDED INTRALUMINA MEDICAL DEVICE; 6,464,720 to Boatman et al. for a RADIALLY EXPANDABLE STENT; 6,231,598 to Berry et al.
  • one or both of the frame members 12 , 14 can be expandable members, such as expandable stents.
  • Expandable stents have two configurations: a first, unexpanded configuration in which the stent has a reduced diameter and a second, expanded configuration in which the stent has an expanded diameter.
  • the unexpanded configuration provides a small profile to the stent, which facilitates advancement and navigation of the stent through a body vessel, such as during percutaneous delivery to a point of treatment in a body vessel.
  • the stent In the expanded configuration, the stent has a larger diameter, which allows the stent to interact with the interior wall of the body vessel.
  • Expandable stents can be self-expandable or may require the application of an outwardly-directed expansile force to induce expansion, such as inflation of an underlying balloon.
  • the first frame member 12 comprises a balloon-expandable stent cut from a solid tube.
  • the second frame member 14 comprises a self-expandable stent comprising a wire frame member.
  • the first frame member 12 in this embodiment comprises a series of interconnected struts 36 and openings 38 .
  • the struts 36 comprise the material of the tube left after cutting, while the openings 38 comprise the spaces left following removal of material during cutting of the tube.
  • the second frame member 14 comprises a plurality of struts 40 interconnected to define a plurality of openings 42 .
  • the second frame member 14 of this embodiment comprises a wire frame stent, which may be formed from one or more wires by braiding, weaving, or other suitable techniques.
  • the first and second frame members 12 , 14 can comprise the same types of frame members.
  • both frame members can be self-expandable or both can be balloon-expandable.
  • a combination of different types of frame members can also be used.
  • the first frame member 12 can be a balloon-expandable stent and the second frame member 14 can be a self-expandable stent.
  • the second, or outer, frame member is self-expandable, it may be advantageous to attach the self-expandable frame member to the graft member, the first, or inner, frame member, or both using any suitable means for attaching members, as described above. This attachment is expected to allow the prosthetic valve to be deployed as a single unit in a single step. If such deployment is not desired, this attachment is not necessary.
  • the first frame member 12 ′ is a self-expandable stent and the second frame member 14 ′ is a balloon-expandable stent.
  • the graft member 16 can be attached to one or both of the frame members 12 , 14 , or can be retained between the frame members 12 , 14 by friction alone. Frictional retention of the graft member 16 can be enhanced by using frame members 12 , 14 of appropriate dimension.
  • the second frame member 14 can have a resting outer diameter that is slightly larger than an inner diameter of a vessel in which the device will be implanted at a point of treatment.
  • the term “resting outer diameter” refers to an outer diameter of a member when the member is free of any constraining force applied by another member or other external factor.
  • the first frame member 12 can also have a resting outer diameter that is slightly larger than a resting inner diameter of the second frame member 14 .
  • graft member 16 A wide variety of materials acceptable for use as the graft member 16 are known in the art, and any suitable material can be used. The material chosen need only be able to perform as described herein, and be biocompatible, or be able to be made biocompatible.
  • suitable materials for the graft member 16 include natural materials, synthetic materials, and combinations thereof. Examples of suitable natural materials include extracellular matrix (ECM) materials, such as small intestine submucosa (SIS), and other bioremodellable materials, such as bovine pericardium.
  • ECM materials extracellular matrix
  • SIS small intestine submucosa
  • Other examples of ECM materials that can be used for the graft member 16 include stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater.
  • suitable synthetic materials include polymeric materials, such as expanded polytetrafluroethylene and polyurethane.
  • ECMs are particularly well suited materials for use in the graft member, at least because of their abilities to remodel and become incorporated into adjacent tissues. These materials can provide a scaffold onto which cellular in-growth can occur, eventually allowing the material to remodel into a structure of host cells.
  • the graft member 16 can be a tubular member, as illustrated in FIGS. 1 and 2 , or may have any other suitable configuration.
  • the graft member 16 ′ comprises first 44 and second 46 graft members.
  • both the first 44 and second 46 graft members are sheets of material disposed between the first 12 and second 14 frame members.
  • the first 44 and second 46 graft members each have semi-circular configurations and can be connected to each other, or can be independently disposed between the frame members 12 , 14 .
  • the first graft member 44 has a portion 20 with an edge 24 that cooperates with an edge 26 of a portion 22 of the second graft member 46 to define the opening 28 of the valve 18 .
  • the graft member 16 comprises a single sheet.
  • the sheet can be rolled so that edges are adjacent each other, or can be held in relative position by compression of the graft between first and second frame members, such as tubular first and second frame members.
  • at least a portion of the graft member 16 is disposed between at least a portion of the first frame member 12 and at least a portion of the second frame member 14 .
  • the graft member 16 can be retained by one or both of the frame members 12 , 14 by friction alone, as described above, or by any other suitable retention mechanism.
  • the graft member 16 can be attached to one or both of the frame members 12 , 14 .
  • any suitable means for attaching two members can be used, and specific, non-limiting examples include sutures, clips, metal and plastic bands, barbs, weld joints, and other attachment elements. The specific means for attaching chosen will depend on several factors, including the nature of the frame member to which the graft member is being attached and the nature of the graft member itself. Sutures provide an acceptable means for attaching a graft member comprising SIS or other ECM material to a metal or plastic frame member.
  • the graft member 16 forms a valve 18 .
  • the valve 18 permits fluid flow through the body vessel in a first direction, and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • the valve 18 can be any suitable type of valve that can be formed by the graft member 16 .
  • the valve 18 can comprise an end portion of a tubular graft member 16 that spans an end of the first frame member 12 in a drum-like fashion.
  • First 20 and second 22 portions of the graft member 16 have first 24 and second 26 edges, respectively, that cooperatively define an opening 28 .
  • the opening 28 opens to permit fluid flow through the body vessel in the first direction, and closes to substantially prevent fluid flow through the body vessel in a second, opposite direction. It is believed that the opening 28 alternates between the open and closed configurations in response to changes in fluid direction and/or pressure within the body vessel.
  • the prosthetic valve 10 includes a valve 18 ′ that comprises an evertable sleeve 48 .
  • An evertable sleeve 48 is a type of valve that comprises a portion of material, the graft member 16 ′′ in this example, that defines the opening 28 .
  • the sleeve 48 includes a first portion 60 disposed between the first 12 and second 14 frame members, and includes a second portion 62 that extends axially away from the frame members 12 , 14 .
  • the sleeve 48 moves into and out of the lumen of the first frame member 12 in response to the direction of flow in the vessel in which the prosthetic valve 10 is implanted.
  • the sleeve 48 When flow proceeds through the body vessel in a first direction, represented by arrow 50 , the sleeve 48 is forced out of the lumen, as illustrated in FIG. 6 , and fluid flows through the interior of the sleeve 48 and through the opening 28 .
  • fluid pressure on the exterior surface of the sleeve 48 forces the sleeve 48 to evert into the lumen of the first frame member 12 .
  • the material of the sleeve 48 collapses upon itself, thereby substantially closing the opening 28 .
  • the valve 18 ′ substantially prevents fluid flow through the body vessel in the second, opposite direction 52 .
  • FIG. 7 illustrates a frame member 112 for use in a prosthetic valve according to an embodiment of the invention.
  • the illustrated frame member 112 is suitable for use as a first frame member in a prosthetic valve according to the invention.
  • the first frame member 112 comprises a tubular member that defines first 160 and second 162 axially-extending extension points.
  • the axially-extending extension points 160 , 162 comprise elongate portions of the first frame member 112 that extend axially away from a circumferential portion of the frame member 112 .
  • the first extension point 160 terminates at an end 164 and has curvilinear base portions 166 , 168 . In alternative embodiments, base positions that are substantially straight are included.
  • the second extension point 162 also terminates at an end 170 and has curvilinear base portions 172 , 174 .
  • Both extension points 160 , 162 extend substantially parallel to a major axis 176 of the first frame member 112 .
  • FIGS. 8 and 9 illustrate a prosthetic valve device 110 according to an embodiment of the invention that incorporates the first frame member 112 illustrated in FIG. 7 .
  • the prosthetic valve device 110 according to this embodiment comprises first 112 and second 114 tubular frame members and a tubular graft member 116 partially disposed between the frame members 112 , 114 .
  • the graft member 116 is attached to the first frame member 112 and forms valve 118 .
  • First 120 and second 122 portions of the graft member 116 are attached to the extension points 160 , 162 defined by the first frame member 112 .
  • the first portion 120 has an edge 124 that cooperates with an edge 126 of the second portion 122 to define an opening 128 .
  • FIG. 8 illustrates the opening 128 in an open configuration, in which the valve permits fluid flow through a body vessel in a first direction
  • FIG. 9 illustrates the opening 128 in a closed configuration, in which the valve 118 substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • An alternative embodiment is similar to the embodiment illustrated in FIGS. 8 and 9 , but includes a self-expandable inner frame member and a balloon-expandable outer frame member, as described above.
  • the first frame member 112 comprises a balloon-expandable stent comprising a plurality of struts 136 and openings 138
  • the second frame member 114 comprises a self-expandable wire frame member comprising a plurality of wire struts 140 that define a plurality of openings 142
  • the second frame member 114 can extend axially along the length of the first frame member 112 to the ends 164 , 170 of the extension points 160 , 162 of the first frame member 112 .
  • the second frame member 114 can extend axially to a point between the curvilinear portions 166 , 168 , 172 , 174 and ends 164 , 170 of the extension points 160 , 162 . Also alternatively, the second frame member 114 can extend axially along any suitable axial length of the first frame member 112 , and can extend axially beyond an axial length of the first frame member 112 .
  • FIG. 10 illustrates a first frame member 112 ′ that includes first 160 ′ and second 162 ′ extension points having an alternative configuration.
  • the extension points 160 ′, 162 ′ each have a length that is greater than an inner diameter (I 1 ) of the frame member 112 ′.
  • I 1 inner diameter
  • Currently contemplated lengths for the extension members in all appropriate embodiments range from between about 10% and about 1000% of the inner diameter (I 1 ) of the first frame member 112 ′.
  • extension members have a length that is ⁇ 50% and ⁇ 400% of an inner diameter (I,) of the first frame member 112 ′.
  • FIG. 11 illustrates the first frame member 112 ′ of FIG. 10 with an attached graft member 116 .
  • the greater length of extension points 160 , 162 may enhance the ability of the valve 118 to function by providing a greater length along which the graft portions 120 , 122 coapt. This may be particularly advantageous for embodiments that include a graft material that may constrict after prolonged implantation, such as ECMs.
  • FIG. 12 illustrates a first frame member 112 ′′ that includes first 160 ′′ and second 162 ′′ extension points having an alternative configuration.
  • the curvilinear portions 166 , 168 ′, 172 ′, 174 ′ are substantially right angles.
  • FIG. 13 illustrates the first frame member 112 ′′ of FIG. 12 with an attached graft member 116 .
  • the substantially right-angled curvilinear portions 166 , 168 , 172 ′, 174 ′ may enhance the ability of the valve 118 to function by providing an increased incidence angle at which fluid flowing in the second, opposite direction, or pressure resulting from such fluid flow, can exert force onto the graft member 116 to close the opening 128 .
  • FIGS. 14 through 16 illustrate a prosthetic valve 210 according to another exemplary embodiment of the invention.
  • the prosthetic valve 210 comprises a first tubular frame member 212 and a second tubular frame member 214 disposed circumferentially around the first tubular frame member 212 .
  • the second tubular frame member 214 defines a sinus portion 280 .
  • the sinus portion 280 is a portion of the second tubular frame member 214 having an enlarged resting outer diameter as compared to the remainder of the frame member 214 .
  • the presence of sinus portion 280 may provide desirable flow dynamics through the prosthetic valve 210 for facilitating clearance of the area between the second frame member 214 and the graft member 216 .
  • the first tubular frame member 212 defines first 260 and second 262 axially-extending extension points.
  • the graft member 216 comprises a tubular member having a first portion 282 that is disposed on an external surface 284 of the second tubular frame member 214 .
  • the first portion 282 of the graft member 216 can be attached to the external surface 284 of the second frame member 214 by any suitable means for attaching, as described above.
  • the graft member 216 further comprises a second portion 286 that is disposed between the first 212 and second 214 tubular frame members.
  • the second portion 286 can be attached to the extension points 260 , 262 .
  • the second portion 286 forms the valve 218 that permits fluid flow through the body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • the graft member 216 comprises a tubular member having a portion 286 that is inverted into the lumen of the tubular graft member 216 .
  • the inverted configuration of the graft member 216 places radially outward directed pressure on the first portion of 282 of the graft member 216 during periods of fluid flow in the second, opposite direction and/or closure of the valve 218 .
  • the radially outward directed pressure will, in turn, direct a force onto an interior wall of a body vessel in which the prosthetic valve 210 is implanted, which may aid in preventing migration of the prosthetic valve 210 in the vessel and/or prevent reflux of fluid around the valve 210 .
  • the radially outward directed force may facilitate incorporation of the first portion 282 into a wall of a body vessel in which the prosthetic valve 210 is implanted.
  • the inverted configuration of the graft member 216 may provide effective closure of the valve 218 with a desirable seal between the prosthetic valve 210 and the interior wall of a body vessel in which the prosthetic valve 210 is implanted.
  • FIG. 14 illustrates the valve 218 in an open configuration
  • FIG. 16 illustrates the valve 218 in a closed configuration
  • FIG. 15 illustrates a magnified view of area 15 in FIG. 14 , showing the relationship between the graft member 216 and the first 212 and second 214 tubular frame members.
  • FIGS. 17 and 18 illustrate a prosthetic valve 310 according to another exemplary embodiment of the invention.
  • the prosthetic valve 310 comprises a first frame member 312 having first 390 and second 392 ends, and a second frame member 314 having third 394 and fourth 396 ends.
  • the third end 394 is disposed radially outward of the first end 390 to create an overlap region of the ends 390 , 394 .
  • the second 392 and fourth 396 ends can comprise flared ends. The presence of one or both flared ends may provide a suitable seal between the prosthetic valve 310 and the interior wall of a body vessel in which the prosthetic valve 310 is implanted.
  • a flared end creates a sinus region in the prosthetic valve 310 that may provide desirable flow dynamics through the prosthetic valve 310 for facilitating clearance of the area between the sides 320 , 322 of the valve 318 and the facing portions of the frame member 314 , i.e., the “valve pockets.” This may reduce pooling of fluid in the valve pockets.
  • a first portion 398 of the graft member 316 is disposed between the first 390 and third 394 ends while a second portion 399 of the graft member 316 is disposed radially inward of the fourth end 396 .
  • a third portion 397 of the graft member 316 is disposed radially outward of the second end 392 .
  • the graft member 316 extends from an interior of the second frame member 314 to an exterior of the first frame member 312 .
  • the second portion 399 of the graft member 316 forms a valve 318 that permits fluid through the body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • the second portion 399 includes first 320 and second 322 sides that define edges 324 , 326 that cooperatively define opening 328 .
  • the second portion 399 of the graft member 316 can be attached to the second frame member 314 using any suitable means for attaching the graft member 316 to the frame member 314 .
  • the second portion 399 can be attached to the frame member 314 in a manner that forms the valve 318 .
  • the third portion 397 is exposed for direct contact with an interior wall of a vessel in which the prosthetic valve 310 is implanted. This may facilitate anchoring of the prosthetic valve 310 , particularly in embodiments in which the graft member 316 comprises a remodellable material, such as an ECM.
  • FIG. 19 is a block diagram illustrating a method 400 of making a prosthetic valve according to the invention.
  • a step 402 of the method 400 comprises providing a first frame member.
  • a step 404 comprises providing a second frame member.
  • a step 406 comprises providing a graft member.
  • a step 408 comprises disposing at least a portion of the graft member between the first and second frame members.
  • a step 410 comprises forming a valve from a portion of the graft member. The valve is formed to permit fluid flow, when implanted in a body vessel, through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction.
  • FIG. 20 is a block diagram illustrating a method 500 of implanting a prosthetic valve according to the invention in a body vessel.
  • a step 502 of the method 500 comprises providing a prosthetic valve comprising first and second frame members and a graft member at least partially disposed between the first and second frame members.
  • the graft member forms a valve that, once implanted in the body vessel, can permit fluid flow through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction.
  • a step 504 comprises percutaneously delivering the prosthetic valve to a point of treatment in a body vessel.
  • the delivering step 504 can be accomplished using any delivery device suitable for percutaneous delivery techniques, including delivery catheters and the like.
  • a step 506 comprises deploying the prosthetic valve.
  • the deploying step 506 can be accomplished in any manner suitable for the delivery device used in the delivering step 504 .
  • FIG. 21 is a block diagram illustrating another method 600 of implanting a prosthetic valve according to the invention in a body vessel.
  • a step 602 of the method 600 comprises providing a first frame member.
  • a step 604 comprises providing a second frame member with an attached graft member.
  • the graft member forms a valve that, once implanted in the body vessel, can permit fluid flow through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction.
  • a step 606 comprises percutaneously delivering the first frame member to a point of treatment in the body vessel.
  • a step 608 comprises deploying the first frame member at the point of treatment.
  • a step 610 comprises percutaneously delivering the second frame member with the attached graft member to the point of treatment in the body vessel.
  • a step 612 comprises deploying the second frame member at the point of treatment. The second frame member is deployed at a position radially inward of the first frame member within the body vessel.
  • percutaneous delivery steps can include the use of percutaneous delivery devices, such as catheters, dilators, sheaths, and/or other suitable endoluminal devices.
  • prosthetic valves of the invention can be placed in body vessels or other desired areas by any suitable technique, including percutaneous delivery as well as surgical placement.

Abstract

Methods of implanting a prosthetic valve in a body vessel are provided. A first expandable frame member is delivered to and deployed at a point of treatment in a body vessel. A second expandable frame member is delivered to the point of treatment. The second expandable frame member has an attached graft member that forms a valve adapted to permit fluid flow through the body vessel in a first direction and to substantially prevent fluid flow through the body vessel in a second, opposite direction. After deployment of the first expandable frame member, the second expandable frame member is deployed at the point of treatment such that the second frame member is positioned radially inward of the first frame member within said body vessel to form a prosthetic valve.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 10/903,907, filed on Jul. 30, 2004, which claims priority to U.S. Provisional Application Ser. No. 60/491,745, filed on Jul. 31, 2003. The entire disclosure of each of these applications is hereby incorporated into this disclosure.
  • FIELD OF THE INVENTION
  • The invention relates to implantable medical devices. More specifically, the invention relates to prosthetic valves for implantation in a body vessel.
  • BACKGROUND OF THE INVENTION
  • Many vessels in animals transport fluids from one bodily location to another. Frequently, fluid flows in a unidirectional manner long the length of the vessel. Varying fluid pressures over time, however, can introduce a temporary reverse flow direction in the vessel. In some vessels, such as mammalian veins, natural valves are positioned along the length of the vessel and act as one-way check valves that open to permit the flow of fluid in the desired direction, and quickly close upon a change in pressure, such as a transition from systole to diastole, to prevent fluid flow in a reverse direction, i.e., retrograde flow.
  • While natural valves may function for an extended time, some may lose effectiveness, which can lead to physical manifestations and pathology. For example, venous valves are susceptible to becoming insufficient due to one or more of a variety of factors. Over time, the vessel wall may stretch, affecting the ability of the leaflets to close. Furthermore, the natural valve leaflets may become damaged, such as by formation of thrombus and scar tissue, which may also affect the ability of the valve leaflets to close. Once a valve is damaged, venous valve insufficiency may be present, and can lead to discomfort and possibly ulcers in the legs and ankles.
  • Current treatments for venous valve insufficiency include the use of compression stockings that are placed around the leg of a patient. Surgical techniques are also employed in which valves can be bypassed, removed, or replaced with autologous sections of veins that include competent valves.
  • Minimally invasive techniques and instruments for placement of intralumenal medical devices have developed over recent years. A wide variety of treatment devices that utilize minimally invasive technology has been developed and includes stents, stent grafts, occlusion devices, infusion catheters and the like. Minimally invasive intravascular devices have especially become popular with the introduction of coronary stents in the U.S. market in the early 1990's. Coronary and peripheral stents have been proven to provide a superior means of maintaining vessel patency, and have become widely accepted in the medical community. Furthermore, the use of stents has been extended to treat aneurisms and to provide occlusion devices, among other uses.
  • Recently, prosthetic valves have been developed that include a support frame such as a stent. In these devices, a graft member can be attached to the support frame to provide a valve function to the device. For example, the graft member can be in the form of a leaflet that is attached to a stent and movable between first and second positions. In a first position, the valve is open and allows fluid flow to proceed through a vessel in a first direction, and in a second position the valve is closed to prevent fluid flow in a second, opposite direction. An example of this type of prosthetic valve is described in commonly owned U.S. Pat. No. 6,508,833, to Pavcnik for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE, which is hereby incorporated by reference in its entirety. In other examples of prosthetic valves, a tube that terminates in leaflets is attached to a support frame to form a valve. The leaflets open to permit fluid flow in a first direction and close to prevent fluid flow in a second, opposite direction. An example of this configuration is provided in U.S. Pat. No. 6,494,909 to Greenhalgh for AN ENDOVASCULAR VALVE, which is hereby incorporated by reference in its entirety.
  • SUMMARY OF EXEMPLARY EMBODIMENTS OF THE INVENTION
  • The invention provides medical devices for implantation in a body vessel. Medical devices according to exemplary embodiments of the invention comprise first and second frame members and a graft member forming a valve that permits fluid flow through a body vessel in a first direction, and substantially prevents fluid flow through the body vessel in a second, opposite direction At least a portion of the graft member is disposed between the frame members.
  • In one exemplary embodiment, a prosthetic valve according to the invention comprises first and second tubular frame members and a graft member disposed between the frame members. The second tubular frame member is circumferentially disposed around the first tubular frame member. The graft member forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • In another exemplary embodiment, a prosthetic valve according to the invention comprises first and second tubular frame members and a graft member disposed between the frame members. The first tubular frame member defines axially-extending extension points and the second tubular frame member is circumferentially disposed around the first tubular frame member. The graft member is attached to the extension points of the first tubular frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • In another exemplary embodiment, a prosthetic valve according to the invention comprises first and second tubular frame members and a tubular graft member. The first tubular frame member defines first and second axially-extending extension points, and the second tubular frame member is circumferentially disposed around the first tubular frame member. The second tubular frame member defines a sinus portion. The graft member has a first portion disposed on an external surface of the second tubular frame member, and a second portion disposed between the first and second tubular frame members. The second portion is attached to the extension points of the first tubular frame member, and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in second, opposite direction.
  • In another exemplary embodiment, a prosthetic valve according to the invention comprises first and second frame members and a graft member. In this embodiment, ends of the frame members overlap and a portion of the graft member is disposed between the overlapping ends. Another portion of the graft member is disposed radially inward of another end of the second frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • In another exemplary embodiment, a prosthetic valve according to the invention comprises first and second tubular frame members and a tubular graft member. An end of the second tubular frame member is disposed circumferentially around an end of the first tubular frame member to form an overlap region. A portion of the tubular graft member is disposed on a portion of an external surface of the first tubular frame member and another portion of the tubular graft member is disposed between the first and second tubular frame members at the overlap region. A third portion of the graft member is attached to a portion of the internal surface of the second tubular frame member and forms a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • The invention also provides methods of making prosthetic valves for implantation in a body vessel. One method according to the invention comprises providing a first frame member, providing a second frame member, providing a graft member, disposing at least a portion of the graft member between the first and second frame members, and forming a valve with the graft member.
  • The invention also provides methods of implanting a prosthetic valve in a body vessel. One method according to the invention comprises providing a prosthetic valve comprising first and second frame members and a graft member disposed between the first and second frame members and forming a valve; percutaneously delivering the prosthetic valve through a body vessel to a point of treatment; and deploying the prosthetic valve at the point of treatment.
  • Another method of implanting a prosthetic valve according to the invention comprises providing a first frame member; providing a second frame member with an attached graft member that forms a valve; percutaneously delivering the first frame member through a body vessel to a point of treatment; deploying the first frame member at the point of treatment; percutaneously delivering the second frame member to the point of treatment; and deploying the second frame member.
  • Additional understanding of the invention can be obtained with review of the description of exemplary embodiments appearing below and reference to the appended drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view, partially broken away, of a prosthetic valve according to a first exemplary embodiment of the invention.
  • FIG. 2 is a cross-sectional view of the prosthetic valve illustrated in FIG. 1, taken along line 2-2.
  • FIG. 3 is a magnified view of area 3 in FIG. 2.
  • FIG. 4 is a magnified view of a prosthetic valve according to an alternative embodiment of the invention.
  • FIG. 5 is a perspective view, partially broken away, of a prosthetic valve according to a second exemplary embodiment of the invention.
  • FIG. 6 is a perspective view, partially broken away, of a prosthetic valve according to a third exemplary embodiment of the invention.
  • FIG. 7 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 8 is a perspective view, partially broken away, of a prosthetic valve according to a fourth exemplary embodiment of the invention that incorporates the frame member illustrated in FIG. 7.
  • FIG. 9 is a perspective view, partially broken away, of the prosthetic valve illustrated in FIG. 8 with the valve in a closed configuration.
  • FIG. 10 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 11 is a perspective view of the frame member illustrated in FIG. 10 with an attached graft member.
  • FIG. 12 is a perspective view of a frame member for use in a prosthetic valve according to an embodiment of the invention.
  • FIG. 13 is a perspective view of the frame member illustrated in FIG. 12 with an attached graft member.
  • FIG. 14 is a perspective view of a prosthetic valve according to a fifth exemplary embodiment of the invention.
  • FIG. 15 is a magnified view of area 15 in FIG. 14.
  • FIG. 16 is a perspective view of the prosthetic valve illustrated in FIG. 14 with the valve in a closed configuration.
  • FIG. 17 is a perspective view of a prosthetic valve according to a sixth exemplary embodiment of the invention.
  • FIG. 18 is a magnified view of area 18 in FIG. 17.
  • FIG. 19 is a block diagram of a method of making a prosthetic valve according to the invention.
  • FIG. 20 is a block diagram of a method of implanting a prosthetic valve according to the invention.
  • FIG. 21 is a block diagram of a method of implanting a prosthetic valve according to the invention.
  • DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS OF THE INVENTION
  • The following provides a detailed description of various exemplary embodiments of the invention. The embodiments described and illustrated herein are exemplary in nature, and serve simply as examples to aid in enabling one of ordinary skill in the art to make and use the invention. The description of exemplary embodiments is not intended to limit the invention, or its protection, in any manner.
  • The invention provides prosthetic valves for use in a body vessel, such as the human vasculature. Prosthetic valves according to the invention comprise first and second frame members and a graft member forming a valve that permits fluid flow through a body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction. At least a portion of the graft member is disposed between the frame members. The inclusion of two frame members in the prosthetic valves of the invention is expected to provide a stable structure for the valves under typical loads for a particular application. Also, it is believed that the inclusion of two frame members will provide a separation between one or more portions of the graft member and an interior wall of a body vessel in which the prosthetic valve is implanted. This separation may protect portions, such as valve leaflets, of graft members formed of certain materials, such as extracellular matrix (ECM) materials, from incorporation into the vessel wall.
  • Medical devices according to the invention can be used as a valve in a variety of body vessels, including within the heart, digestive tract, and other body vessels. Exemplary embodiments of the invention are particularly well suited for use as percutaneously delivered prosthetic venous valves.
  • FIGS. 1 through 3 illustrate a prosthetic valve 10 according to a first exemplary embodiment of the invention. In this embodiment, the prosthetic valve 10 comprises a first frame member 12, a second frame member 14, and a graft member 16 partially disposed between the first 12 and second 14 frame members. As best illustrated in FIG. 2, the second frame member 14 is disposed radially outward from the first frame member 12. That is, the second frame member 14 intersects a hypothetical radial line 13 extending from a hypothetical central point 15 and through the frame members 12, 14 at a point further from the central point 15 than a point at which the first frame member 12 intersects the line 13. In this embodiment, the first 12 and second 14 frame members comprise tubular members, and the first frame member 12 is disposed within a lumen defined by the second frame member 14. Thus, the second frame member 14 is disposed circumferentially around the first frame member 12. Also in this embodiment, as best illustrated in FIG. 1, the first 12 and second 14 frame members have substantially the same axial lengths.
  • The first 12 and second 14 frame members comprise structural bodies having one or more surfaces. The first frame member 12 has an exterior surface 30 that can include an adhesive 32 or other means for attaching the graft member 16 to the frame member 12. Any suitable means for attaching two members can be used, and specific, non-limiting examples include sutures, clips, metal and plastic bands, barbs, weld joints, and other attachment elements. The second frame member 14 has an interior surface 34 that may also include an adhesive or other means for attaching (not illustrated in FIGS. 1 through 3) the graft member 16 to the second frame member 14.
  • Each of the frame members 12, 14 can comprise any suitable frame that provides the desired surfaces between which a portion of the graft member 16 can be disposed. As best illustrated in FIGS. 1 and 2, each frame member 12, 14 can comprise a tubular frame member. Medical stents provide tubular frame members, and any suitable medical stent can be used in the prosthetic valves of the invention. It is noted, though, that the frame member(s) need not provide a stenting function; such a function is optional. If one or more stents are used in a prosthetic valve according to the invention, the stent can be any suitable type of stent, including a wire frame member, a solid tubular member, a tubular member with openings cut therein, or any other suitable medical stent. Examples of suitable stents for use in the prosthetic valves of the invention include the stents described in U.S. Pat. Nos. 6,508,833 to Pavcnik et al. for a MULTIPLE-SIDED INTRALUMINA MEDICAL DEVICE; 6,464,720 to Boatman et al. for a RADIALLY EXPANDABLE STENT; 6,231,598 to Berry et al. for a RADIALLY EXPANDABLE STENT; 6,299,635 to Frantzen for a RADIALY EXPANDABLE NON-AXIALLY CONTRACTING SURGICAL STENT; 4,580,568 to Gianturco for a PERCUTANEOUS ENDOVASCULAR STENT AND METHOD FOR INSERTION THEREOF; and Published Application for United States Patent 20010039450 to Pavcnik et al. for an IMPLANTABLE MEDICAL DEVICE, all of which are hereby incorporated by reference in their entirety for the purpose of describing suitable stents for use in the invention.
  • To facilitate delivery of the prosthetic valves of the invention, one or both of the frame members 12, 14 can be expandable members, such as expandable stents. Expandable stents have two configurations: a first, unexpanded configuration in which the stent has a reduced diameter and a second, expanded configuration in which the stent has an expanded diameter. The unexpanded configuration provides a small profile to the stent, which facilitates advancement and navigation of the stent through a body vessel, such as during percutaneous delivery to a point of treatment in a body vessel. In the expanded configuration, the stent has a larger diameter, which allows the stent to interact with the interior wall of the body vessel. Expandable stents can be self-expandable or may require the application of an outwardly-directed expansile force to induce expansion, such as inflation of an underlying balloon.
  • In the embodiment illustrated in FIGS. 1 through 3, the first frame member 12 comprises a balloon-expandable stent cut from a solid tube. The second frame member 14 comprises a self-expandable stent comprising a wire frame member. The first frame member 12 in this embodiment comprises a series of interconnected struts 36 and openings 38. The struts 36 comprise the material of the tube left after cutting, while the openings 38 comprise the spaces left following removal of material during cutting of the tube. The second frame member 14 comprises a plurality of struts 40 interconnected to define a plurality of openings 42. The second frame member 14 of this embodiment comprises a wire frame stent, which may be formed from one or more wires by braiding, weaving, or other suitable techniques.
  • In prosthetic valves according to the invention, the first and second frame members 12, 14 can comprise the same types of frame members. For example, both frame members can be self-expandable or both can be balloon-expandable. A combination of different types of frame members can also be used. For example, as illustrated in FIGS. 1 through 3, the first frame member 12 can be a balloon-expandable stent and the second frame member 14 can be a self-expandable stent. In embodiments in which the second, or outer, frame member is self-expandable, it may be advantageous to attach the self-expandable frame member to the graft member, the first, or inner, frame member, or both using any suitable means for attaching members, as described above. This attachment is expected to allow the prosthetic valve to be deployed as a single unit in a single step. If such deployment is not desired, this attachment is not necessary.
  • In an alternative embodiment, illustrated in FIG. 4, the first frame member 12′ is a self-expandable stent and the second frame member 14′ is a balloon-expandable stent.
  • As described more fully below, the graft member 16 can be attached to one or both of the frame members 12, 14, or can be retained between the frame members 12, 14 by friction alone. Frictional retention of the graft member 16 can be enhanced by using frame members 12, 14 of appropriate dimension. For example, the second frame member 14 can have a resting outer diameter that is slightly larger than an inner diameter of a vessel in which the device will be implanted at a point of treatment. As used herein, the term “resting outer diameter” refers to an outer diameter of a member when the member is free of any constraining force applied by another member or other external factor. The first frame member 12 can also have a resting outer diameter that is slightly larger than a resting inner diameter of the second frame member 14. These configurations of the frame members 12, 14 will ensure that a force will be exerted upon a member disposed between the frame members 12, 14, such as the graft member 16, thereby enhancing frictional retention of the member.
  • A wide variety of materials acceptable for use as the graft member 16 are known in the art, and any suitable material can be used. The material chosen need only be able to perform as described herein, and be biocompatible, or be able to be made biocompatible. Examples of suitable materials for the graft member 16 include natural materials, synthetic materials, and combinations thereof. Examples of suitable natural materials include extracellular matrix (ECM) materials, such as small intestine submucosa (SIS), and other bioremodellable materials, such as bovine pericardium. Other examples of ECM materials that can be used for the graft member 16 include stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater. Examples of suitable synthetic materials include polymeric materials, such as expanded polytetrafluroethylene and polyurethane. ECMs are particularly well suited materials for use in the graft member, at least because of their abilities to remodel and become incorporated into adjacent tissues. These materials can provide a scaffold onto which cellular in-growth can occur, eventually allowing the material to remodel into a structure of host cells.
  • The graft member 16 can be a tubular member, as illustrated in FIGS. 1 and 2, or may have any other suitable configuration. For example, in the exemplary embodiment illustrated in FIG. 5, the graft member 16′ comprises first 44 and second 46 graft members. In this embodiment, both the first 44 and second 46 graft members are sheets of material disposed between the first 12 and second 14 frame members. The first 44 and second 46 graft members each have semi-circular configurations and can be connected to each other, or can be independently disposed between the frame members 12, 14. The first graft member 44 has a portion 20 with an edge 24 that cooperates with an edge 26 of a portion 22 of the second graft member 46 to define the opening 28 of the valve 18. The specific form chosen for the graft member 16 will depend on several factors, including the form of the valve 18 and the mechanism by which the first 12 and/or second 14 frame members retain the graft member 16. In another alternative embodiment, the graft member comprises a single sheet. In this embodiment, the sheet can be rolled so that edges are adjacent each other, or can be held in relative position by compression of the graft between first and second frame members, such as tubular first and second frame members. In all embodiments, at least a portion of the graft member 16 is disposed between at least a portion of the first frame member 12 and at least a portion of the second frame member 14.
  • The graft member 16 can be retained by one or both of the frame members 12, 14 by friction alone, as described above, or by any other suitable retention mechanism. For example, the graft member 16 can be attached to one or both of the frame members 12, 14. In embodiments in which the graft member 16 is attached to one or both of the frame members 12, 14, any suitable means for attaching two members can be used, and specific, non-limiting examples include sutures, clips, metal and plastic bands, barbs, weld joints, and other attachment elements. The specific means for attaching chosen will depend on several factors, including the nature of the frame member to which the graft member is being attached and the nature of the graft member itself. Sutures provide an acceptable means for attaching a graft member comprising SIS or other ECM material to a metal or plastic frame member.
  • The graft member 16 forms a valve 18. When a prosthetic valve according to the invention is implanted in a body vessel, the valve 18 permits fluid flow through the body vessel in a first direction, and substantially prevents fluid flow through the body vessel in a second, opposite direction. The valve 18 can be any suitable type of valve that can be formed by the graft member 16. As illustrated in FIG. 1, the valve 18 can comprise an end portion of a tubular graft member 16 that spans an end of the first frame member 12 in a drum-like fashion. First 20 and second 22 portions of the graft member 16 have first 24 and second 26 edges, respectively, that cooperatively define an opening 28. The opening 28 opens to permit fluid flow through the body vessel in the first direction, and closes to substantially prevent fluid flow through the body vessel in a second, opposite direction. It is believed that the opening 28 alternates between the open and closed configurations in response to changes in fluid direction and/or pressure within the body vessel.
  • In FIG. 6, the prosthetic valve 10 includes a valve 18′ that comprises an evertable sleeve 48. An evertable sleeve 48 is a type of valve that comprises a portion of material, the graft member 16″ in this example, that defines the opening 28. The sleeve 48 includes a first portion 60 disposed between the first 12 and second 14 frame members, and includes a second portion 62 that extends axially away from the frame members 12, 14. The sleeve 48 moves into and out of the lumen of the first frame member 12 in response to the direction of flow in the vessel in which the prosthetic valve 10 is implanted. When flow proceeds through the body vessel in a first direction, represented by arrow 50, the sleeve 48 is forced out of the lumen, as illustrated in FIG. 6, and fluid flows through the interior of the sleeve 48 and through the opening 28. When fluid flows through the body vessel in a second, opposite direction, represented by arrow 52, fluid pressure on the exterior surface of the sleeve 48 forces the sleeve 48 to evert into the lumen of the first frame member 12. In this configuration, the material of the sleeve 48 collapses upon itself, thereby substantially closing the opening 28. As a result, the valve 18′ substantially prevents fluid flow through the body vessel in the second, opposite direction 52.
  • FIG. 7 illustrates a frame member 112 for use in a prosthetic valve according to an embodiment of the invention. The illustrated frame member 112 is suitable for use as a first frame member in a prosthetic valve according to the invention. The first frame member 112 comprises a tubular member that defines first 160 and second 162 axially-extending extension points. The axially-extending extension points 160, 162, comprise elongate portions of the first frame member 112 that extend axially away from a circumferential portion of the frame member 112. The first extension point 160 terminates at an end 164 and has curvilinear base portions 166, 168. In alternative embodiments, base positions that are substantially straight are included. The second extension point 162 also terminates at an end 170 and has curvilinear base portions 172, 174. Both extension points 160, 162 extend substantially parallel to a major axis 176 of the first frame member 112.
  • FIGS. 8 and 9 illustrate a prosthetic valve device 110 according to an embodiment of the invention that incorporates the first frame member 112 illustrated in FIG. 7. The prosthetic valve device 110 according to this embodiment comprises first 112 and second 114 tubular frame members and a tubular graft member 116 partially disposed between the frame members 112, 114. The graft member 116 is attached to the first frame member 112 and forms valve 118. First 120 and second 122 portions of the graft member 116 are attached to the extension points 160, 162 defined by the first frame member 112. The first portion 120 has an edge 124 that cooperates with an edge 126 of the second portion 122 to define an opening 128. FIG. 8 illustrates the opening 128 in an open configuration, in which the valve permits fluid flow through a body vessel in a first direction, while FIG. 9 illustrates the opening 128 in a closed configuration, in which the valve 118 substantially prevents fluid flow through the body vessel in a second, opposite direction. An alternative embodiment is similar to the embodiment illustrated in FIGS. 8 and 9, but includes a self-expandable inner frame member and a balloon-expandable outer frame member, as described above.
  • In this embodiment, the first frame member 112 comprises a balloon-expandable stent comprising a plurality of struts 136 and openings 138, while the second frame member 114 comprises a self-expandable wire frame member comprising a plurality of wire struts 140 that define a plurality of openings 142. The second frame member 114 can extend axially along the length of the first frame member 112 to the ends 164, 170 of the extension points 160, 162 of the first frame member 112. Alternatively, the second frame member 114 can extend axially to a point between the curvilinear portions 166, 168, 172, 174 and ends 164, 170 of the extension points 160, 162. Also alternatively, the second frame member 114 can extend axially along any suitable axial length of the first frame member 112, and can extend axially beyond an axial length of the first frame member 112.
  • FIG. 10 illustrates a first frame member 112′ that includes first 160′ and second 162′ extension points having an alternative configuration. In this embodiment, the extension points 160′, 162′ each have a length that is greater than an inner diameter (I1) of the frame member 112′. Currently contemplated lengths for the extension members in all appropriate embodiments range from between about 10% and about 1000% of the inner diameter (I1) of the first frame member 112′. In exemplary embodiments, extension members have a length that is ≧50% and ≦400% of an inner diameter (I,) of the first frame member 112′.
  • FIG. 11 illustrates the first frame member 112′ of FIG. 10 with an attached graft member 116. The greater length of extension points 160, 162, as described above, may enhance the ability of the valve 118 to function by providing a greater length along which the graft portions 120, 122 coapt. This may be particularly advantageous for embodiments that include a graft material that may constrict after prolonged implantation, such as ECMs.
  • FIG. 12 illustrates a first frame member 112″ that includes first 160″ and second 162″ extension points having an alternative configuration. In this embodiment, the curvilinear portions 166, 168′, 172′, 174′ are substantially right angles.
  • FIG. 13 illustrates the first frame member 112″ of FIG. 12 with an attached graft member 116. The substantially right-angled curvilinear portions 166, 168, 172′, 174′ may enhance the ability of the valve 118 to function by providing an increased incidence angle at which fluid flowing in the second, opposite direction, or pressure resulting from such fluid flow, can exert force onto the graft member 116 to close the opening 128.
  • FIGS. 14 through 16 illustrate a prosthetic valve 210 according to another exemplary embodiment of the invention. In this embodiment, the prosthetic valve 210 comprises a first tubular frame member 212 and a second tubular frame member 214 disposed circumferentially around the first tubular frame member 212. The second tubular frame member 214 defines a sinus portion 280. The sinus portion 280 is a portion of the second tubular frame member 214 having an enlarged resting outer diameter as compared to the remainder of the frame member 214. The presence of sinus portion 280 may provide desirable flow dynamics through the prosthetic valve 210 for facilitating clearance of the area between the second frame member 214 and the graft member 216. Also in this embodiment, the first tubular frame member 212 defines first 260 and second 262 axially-extending extension points.
  • The graft member 216 comprises a tubular member having a first portion 282 that is disposed on an external surface 284 of the second tubular frame member 214. The first portion 282 of the graft member 216 can be attached to the external surface 284 of the second frame member 214 by any suitable means for attaching, as described above. The graft member 216 further comprises a second portion 286 that is disposed between the first 212 and second 214 tubular frame members. The second portion 286 can be attached to the extension points 260, 262. The second portion 286 forms the valve 218 that permits fluid flow through the body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction.
  • In this embodiment, the graft member 216 comprises a tubular member having a portion 286 that is inverted into the lumen of the tubular graft member 216. The inverted configuration of the graft member 216 places radially outward directed pressure on the first portion of 282 of the graft member 216 during periods of fluid flow in the second, opposite direction and/or closure of the valve 218. The radially outward directed pressure will, in turn, direct a force onto an interior wall of a body vessel in which the prosthetic valve 210 is implanted, which may aid in preventing migration of the prosthetic valve 210 in the vessel and/or prevent reflux of fluid around the valve 210. Further, if a remodellable or other natural material is used in the graft member 216, the radially outward directed force may facilitate incorporation of the first portion 282 into a wall of a body vessel in which the prosthetic valve 210 is implanted. Thus, the inverted configuration of the graft member 216 may provide effective closure of the valve 218 with a desirable seal between the prosthetic valve 210 and the interior wall of a body vessel in which the prosthetic valve 210 is implanted.
  • FIG. 14 illustrates the valve 218 in an open configuration, while FIG. 16 illustrates the valve 218 in a closed configuration. FIG. 15 illustrates a magnified view of area 15 in FIG. 14, showing the relationship between the graft member 216 and the first 212 and second 214 tubular frame members.
  • FIGS. 17 and 18 illustrate a prosthetic valve 310 according to another exemplary embodiment of the invention. In this embodiment, the prosthetic valve 310 comprises a first frame member 312 having first 390 and second 392 ends, and a second frame member 314 having third 394 and fourth 396 ends. The third end 394 is disposed radially outward of the first end 390 to create an overlap region of the ends 390, 394. As illustrated in FIG. 17, the second 392 and fourth 396 ends can comprise flared ends. The presence of one or both flared ends may provide a suitable seal between the prosthetic valve 310 and the interior wall of a body vessel in which the prosthetic valve 310 is implanted. Also, a flared end creates a sinus region in the prosthetic valve 310 that may provide desirable flow dynamics through the prosthetic valve 310 for facilitating clearance of the area between the sides 320, 322 of the valve 318 and the facing portions of the frame member 314, i.e., the “valve pockets.” This may reduce pooling of fluid in the valve pockets.
  • A first portion 398 of the graft member 316 is disposed between the first 390 and third 394 ends while a second portion 399 of the graft member 316 is disposed radially inward of the fourth end 396. A third portion 397 of the graft member 316 is disposed radially outward of the second end 392. Thus, the graft member 316 extends from an interior of the second frame member 314 to an exterior of the first frame member 312. The second portion 399 of the graft member 316 forms a valve 318 that permits fluid through the body vessel in a first direction and substantially prevents fluid flow through the body vessel in a second, opposite direction. The second portion 399 includes first 320 and second 322 sides that define edges 324, 326 that cooperatively define opening 328. The second portion 399 of the graft member 316 can be attached to the second frame member 314 using any suitable means for attaching the graft member 316 to the frame member 314. The second portion 399 can be attached to the frame member 314 in a manner that forms the valve 318. The third portion 397 is exposed for direct contact with an interior wall of a vessel in which the prosthetic valve 310 is implanted. This may facilitate anchoring of the prosthetic valve 310, particularly in embodiments in which the graft member 316 comprises a remodellable material, such as an ECM.
  • The invention also provides methods of making prosthetic valves for implantation in body vessels. FIG. 19 is a block diagram illustrating a method 400 of making a prosthetic valve according to the invention. A step 402 of the method 400 comprises providing a first frame member. A step 404 comprises providing a second frame member. A step 406 comprises providing a graft member. A step 408 comprises disposing at least a portion of the graft member between the first and second frame members. A step 410 comprises forming a valve from a portion of the graft member. The valve is formed to permit fluid flow, when implanted in a body vessel, through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction.
  • The invention also provides methods of implanting prosthetic valves in a body vessel. FIG. 20 is a block diagram illustrating a method 500 of implanting a prosthetic valve according to the invention in a body vessel. A step 502 of the method 500 comprises providing a prosthetic valve comprising first and second frame members and a graft member at least partially disposed between the first and second frame members. The graft member forms a valve that, once implanted in the body vessel, can permit fluid flow through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction. A step 504 comprises percutaneously delivering the prosthetic valve to a point of treatment in a body vessel. The delivering step 504 can be accomplished using any delivery device suitable for percutaneous delivery techniques, including delivery catheters and the like. A step 506 comprises deploying the prosthetic valve. The deploying step 506 can be accomplished in any manner suitable for the delivery device used in the delivering step 504.
  • FIG. 21 is a block diagram illustrating another method 600 of implanting a prosthetic valve according to the invention in a body vessel. A step 602 of the method 600 comprises providing a first frame member. A step 604 comprises providing a second frame member with an attached graft member. The graft member forms a valve that, once implanted in the body vessel, can permit fluid flow through the body vessel in a first direction and substantially prevent fluid flow through the body vessel in a second, opposite direction. A step 606 comprises percutaneously delivering the first frame member to a point of treatment in the body vessel. A step 608 comprises deploying the first frame member at the point of treatment. A step 610 comprises percutaneously delivering the second frame member with the attached graft member to the point of treatment in the body vessel. A step 612 comprises deploying the second frame member at the point of treatment. The second frame member is deployed at a position radially inward of the first frame member within the body vessel.
  • In all methods of implanting prosthetic valves according to the invention, percutaneous delivery steps can include the use of percutaneous delivery devices, such as catheters, dilators, sheaths, and/or other suitable endoluminal devices.
  • It is noted that the prosthetic valves of the invention can be placed in body vessels or other desired areas by any suitable technique, including percutaneous delivery as well as surgical placement.
  • The foregoing detailed description provides exemplary embodiments of the invention and includes the best mode for practicing the invention. These embodiments are intended only to serve as examples of the invention, and not to limit the scope of the invention, or its protection, in any manner.

Claims (20)

1. A method of implanting a prosthetic valve in a body vessel, comprising:
providing a first expandable frame member having unexpanded and expanded configurations;
providing a second expandable frame member having unexpanded and expanded configurations, the second expandable frame member having an attached graft member forming a valve adapted to permit fluid flow through said body vessel in a first direction and to substantially prevent fluid flow through said body vessel in a second, opposite direction;
percutaneously delivering the first frame member to a point of treatment in said body vessel;
deploying the first frame member at the point of treatment;
percutaneously delivering the second frame member with the attached graft member to the point of treatment;
after deploying the first frame member at the point of treatment, deploying the second frame member with the attached graft member at the point of treatment such that the second frame member is positioned radially inward of the first frame member within said body vessel to form said prosthetic valve.
2. The method of claim 1, wherein at least one of the first expandable frame member and the second expandable frame member comprises a self-expandable member.
3. The method of claim 1, wherein at least one of the first expandable frame member and the second expandable frame member requires the application of an outwardly-directed expansile force to induce expansion.
4. The method of claim 1, wherein at least one of the first expandable frame member and the second expandable frame member comprises a tubular member.
5. The method of claim 1, wherein at least one of the first expandable frame member and the second expandable frame member comprises a stent.
6. The method of claim 6, wherein at least one of the first expandable frame member and the second expandable frame member comprises a wire frame member.
7. The method of claim 6, wherein at least one of the first expandable frame member and the second expandable frame member comprises a solid tubular member.
8. The method of claim 6, wherein at least one of the first expandable frame member and the second expandable frame member comprises a tubular member with openings therein.
9. The method of claim 1, wherein one of the first expandable frame member and the second expandable frame member comprises a self-expandable frame member and the other of the first expandable frame member and the second expandable frame member requires the application of an outwardly-directed expansile force to induce expansion.
10. The method of claim 1, wherein the graft member comprises a natural material.
11. The method of claim 10, wherein the graft member comprises a bioremodellable material.
12. The method of claim 10, wherein the graft member comprises an extracellular matrix material.
13. The method of claim 10, wherein the graft member comprises small intestine submucosa.
14. The method of claim 1, wherein the graft member comprises a synthetic material.
15. The method of claim 14, wherein the graft member comprises a polymeric material.
16. The method of claim 14, wherein the graft member comprises one of expanded polytetrafluoroethylene and polyurethane.
17. The method of claim 1, wherein the graft member comprises a tubular member.
18. The method of claim 1, wherein the first frame member defines a sinus portion.
19. A method of implanting a prosthetic valve in a body vessel, comprising:
providing a first expandable frame member having unexpanded and expanded configurations, the first frame member defining a sinus portion;
providing a second expandable frame member having unexpanded and expanded configurations, the second expandable frame member having an attached graft member forming a valve adapted to permit fluid flow through said body vessel in a first direction and to substantially prevent fluid flow through said body vessel in a second, opposite direction;
percutaneously delivering the first frame member to a point of treatment in said body vessel;
deploying the first frame member at the point of treatment;
percutaneously delivering the second frame member with the attached graft member to the point of treatment;
after deploying the first frame member at the point of treatment, deploying the second frame member with the attached graft member at the point of treatment such that the second frame member is positioned radially inward of the first frame member within said body vessel to form said prosthetic valve.
20. A method of implanting a prosthetic valve in a body vessel, comprising:
providing a first expandable frame member having unexpanded and expanded configurations, the first frame member having a first axial length and defining a sinus portion;
providing a second expandable frame member having unexpanded and expanded configurations, the second expandable frame member having a second axial length and an attached graft member forming a valve adapted to permit fluid flow through said body vessel in a first direction and to substantially prevent fluid flow through said body vessel in a second, opposite direction, the first axial length being greater than the second axial length;
percutaneously delivering the first frame member to a point of treatment in said body vessel;
deploying the first frame member at the point of treatment;
percutaneously delivering the second frame member with the attached graft member to the point of treatment;
after deploying the first frame member at the point of treatment, deploying the second frame member with the attached graft member at the point of treatment such that the second frame member is positioned radially inward of the first frame member within said body vessel and such that the valve is positioned substantially adjacent the sinus portion to form said prosthetic valve.
US12/621,214 2003-07-31 2009-11-18 Method of implanting a prosthetic valve Abandoned US20100063577A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/621,214 US20100063577A1 (en) 2003-07-31 2009-11-18 Method of implanting a prosthetic valve

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49174503P 2003-07-31 2003-07-31
US10/903,907 US7686844B2 (en) 2003-07-31 2004-07-31 Prosthetic valve for implantation in a body vessel
US12/621,214 US20100063577A1 (en) 2003-07-31 2009-11-18 Method of implanting a prosthetic valve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/903,907 Continuation US7686844B2 (en) 2003-07-31 2004-07-31 Prosthetic valve for implantation in a body vessel

Publications (1)

Publication Number Publication Date
US20100063577A1 true US20100063577A1 (en) 2010-03-11

Family

ID=34115546

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/903,907 Active 2025-07-19 US7686844B2 (en) 2003-07-31 2004-07-31 Prosthetic valve for implantation in a body vessel
US12/621,214 Abandoned US20100063577A1 (en) 2003-07-31 2009-11-18 Method of implanting a prosthetic valve

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/903,907 Active 2025-07-19 US7686844B2 (en) 2003-07-31 2004-07-31 Prosthetic valve for implantation in a body vessel

Country Status (2)

Country Link
US (2) US7686844B2 (en)
WO (1) WO2005011535A2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090125098A1 (en) * 2007-11-09 2009-05-14 Cook Incorporated Aortic valve stent graft
US20100233235A1 (en) * 2009-02-18 2010-09-16 Matheny Robert G Compositions and methods for preventing cardiac arrhythmia
US20110066237A1 (en) * 2007-12-18 2011-03-17 Matheny Robert G Prosthetic tissue valve
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8696744B2 (en) 2011-05-27 2014-04-15 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
WO2014133543A1 (en) * 2013-03-01 2014-09-04 Cormatrix Cardiovascular, Inc. Two-piece prosthetic valve
WO2015123607A3 (en) * 2014-02-13 2016-02-25 Valvexchange, Inc. Temporary sub-valvular check valve
US20170156863A1 (en) * 2015-12-03 2017-06-08 Medtronic Vascular, Inc. Venous valve prostheses
US10695171B2 (en) 2010-11-05 2020-06-30 Cook Medical Technologies Llc Stent structures for use with valve replacements
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US11406495B2 (en) 2013-02-11 2022-08-09 Cook Medical Technologies Llc Expandable support frame and medical device

Families Citing this family (262)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
WO2002005888A1 (en) 2000-06-30 2002-01-24 Viacor Incorporated Intravascular filter with debris entrapment mechanism
JP2004506469A (en) 2000-08-18 2004-03-04 アトリテック, インコーポレイテッド Expandable implantable device for filtering blood flow from the atrial appendage
WO2004030568A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Device and method for repairing a native heart valve leaflet
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US8038708B2 (en) * 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7097659B2 (en) 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US8721713B2 (en) 2002-04-23 2014-05-13 Medtronic, Inc. System for implanting a replacement valve
US7837669B2 (en) * 2002-11-01 2010-11-23 Valentx, Inc. Devices and methods for endolumenal gastrointestinal bypass
US7794447B2 (en) * 2002-11-01 2010-09-14 Valentx, Inc. Gastrointestinal sleeve device and methods for treatment of morbid obesity
US8070743B2 (en) 2002-11-01 2011-12-06 Valentx, Inc. Devices and methods for attaching an endolumenal gastrointestinal implant
US9060844B2 (en) 2002-11-01 2015-06-23 Valentx, Inc. Apparatus and methods for treatment of morbid obesity
US7766973B2 (en) * 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
WO2005011535A2 (en) * 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
EP1702247B8 (en) 2003-12-23 2015-09-09 Boston Scientific Scimed, Inc. Repositionable heart valve
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
BRPI0510107A (en) 2004-04-23 2007-09-25 3F Therapeutics Inc implantable protein valve
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
US20060155375A1 (en) * 2004-09-27 2006-07-13 Jonathan Kagan Devices and methods for attachment of a gastrointestinal sleeve
US8562672B2 (en) * 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
EP1848368A1 (en) 2004-12-20 2007-10-31 Cook Incorporated Intraluminal support frame and medical devices including the support frame
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US20060173490A1 (en) 2005-02-01 2006-08-03 Boston Scientific Scimed, Inc. Filter system and method
US7854755B2 (en) 2005-02-01 2010-12-21 Boston Scientific Scimed, Inc. Vascular catheter, system, and method
US7878966B2 (en) 2005-02-04 2011-02-01 Boston Scientific Scimed, Inc. Ventricular assist and support device
US7670368B2 (en) 2005-02-07 2010-03-02 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US7780722B2 (en) 2005-02-07 2010-08-24 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
ITTO20050074A1 (en) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
US7867274B2 (en) 2005-02-23 2011-01-11 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7722666B2 (en) 2005-04-15 2010-05-25 Boston Scientific Scimed, Inc. Valve apparatus, system and method
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US8663312B2 (en) * 2005-05-27 2014-03-04 Hlt, Inc. Intravascular cuff
US8012198B2 (en) 2005-06-10 2011-09-06 Boston Scientific Scimed, Inc. Venous valve, system, and method
WO2007016251A2 (en) * 2005-07-28 2007-02-08 Cook Incorporated Implantable thromboresistant valve
US7569071B2 (en) 2005-09-21 2009-08-04 Boston Scientific Scimed, Inc. Venous valve, system, and method with sinus pocket
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9078781B2 (en) 2006-01-11 2015-07-14 Medtronic, Inc. Sterile cover for compressible stents used in percutaneous device delivery systems
US7799038B2 (en) 2006-01-20 2010-09-21 Boston Scientific Scimed, Inc. Translumenal apparatus, system, and method
WO2007097983A2 (en) 2006-02-14 2007-08-30 Sadra Medical, Inc. Systems and methods for delivering a medical implant
US8075615B2 (en) 2006-03-28 2011-12-13 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
US7881797B2 (en) * 2006-04-25 2011-02-01 Valentx, Inc. Methods and devices for gastrointestinal stimulation
WO2008001381A2 (en) * 2006-06-29 2008-01-03 Slimedics, Ltd. Gastrointestinal prostheses
US8257429B2 (en) * 2006-08-21 2012-09-04 Oregon Health & Science University Biomedical valve devices, support frames for use in such devices, and related methods
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8414643B2 (en) 2006-09-19 2013-04-09 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US20080167610A1 (en) * 2006-09-25 2008-07-10 Valentx, Inc. Toposcopic methods and devices for delivering a sleeve having axially compressed and elongate configurations
WO2008047354A2 (en) 2006-10-16 2008-04-24 Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
US20100070019A1 (en) * 2006-10-29 2010-03-18 Aneuwrap Ltd. extra-vascular wrapping for treating aneurysmatic aorta and methods thereof
WO2008070797A2 (en) 2006-12-06 2008-06-12 Medtronic Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US8133270B2 (en) 2007-01-08 2012-03-13 California Institute Of Technology In-situ formation of a valve
US8388679B2 (en) 2007-01-19 2013-03-05 Maquet Cardiovascular Llc Single continuous piece prosthetic tubular aortic conduit and method for manufacturing the same
JP5313928B2 (en) 2007-02-05 2013-10-09 ボストン サイエンティフィック リミテッド Percutaneous valves and systems
US8623074B2 (en) 2007-02-16 2014-01-07 Medtronic, Inc. Delivery systems and methods of implantation for replacement prosthetic heart valves
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
FR2915087B1 (en) 2007-04-20 2021-11-26 Corevalve Inc IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.
MX2009013568A (en) * 2007-06-11 2010-04-21 Valentx Inc Endoscopic delivery devices and methods.
US8828079B2 (en) 2007-07-26 2014-09-09 Boston Scientific Scimed, Inc. Circulatory valve, system and method
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US7846199B2 (en) * 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
US7892276B2 (en) 2007-12-21 2011-02-22 Boston Scientific Scimed, Inc. Valve with delayed leaflet deployment
US7854759B2 (en) * 2007-12-21 2010-12-21 Cook Incorporated Prosthetic flow modifying device
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
EP3572044B1 (en) 2008-01-24 2021-07-28 Medtronic, Inc. Stents for prosthetic heart valves
US9089422B2 (en) 2008-01-24 2015-07-28 Medtronic, Inc. Markers for prosthetic heart valves
US8157853B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US20090264989A1 (en) 2008-02-28 2009-10-22 Philipp Bonhoeffer Prosthetic heart valve systems
US8696689B2 (en) * 2008-03-18 2014-04-15 Medtronic Ventor Technologies Ltd. Medical suturing device and method for use thereof
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
EP2119417B2 (en) 2008-05-16 2020-04-29 Sorin Group Italia S.r.l. Atraumatic prosthetic heart valve prosthesis
US20100023114A1 (en) * 2008-07-24 2010-01-28 Cook Incorporated Valve device with biased leaflets
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
ES2409693T3 (en) 2008-10-10 2013-06-27 Sadra Medical, Inc. Medical devices and supply systems to supply medical devices
US8137398B2 (en) 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
US8343088B2 (en) * 2008-10-21 2013-01-01 Douglas Bates Apparatus and method for treating occluded infection collections of the digestive tract
EP2201911B1 (en) 2008-12-23 2015-09-30 Sorin Group Italia S.r.l. Expandable prosthetic valve having anchoring appendages
EP2246011B1 (en) 2009-04-27 2014-09-03 Sorin Group Italia S.r.l. Prosthetic vascular conduit
EP2445444B1 (en) 2009-06-23 2018-09-26 Endospan Ltd. Vascular prostheses for treating aneurysms
CA2767596C (en) 2009-07-09 2015-11-24 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
WO2011064782A2 (en) 2009-11-30 2011-06-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
AU2010328106A1 (en) 2009-12-08 2012-07-05 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
WO2011070576A1 (en) 2009-12-08 2011-06-16 Endospan Ltd. Endovascular stent-graft system with fenestrated and crossing stent-grafts
CA2789304C (en) 2010-02-08 2018-01-02 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US20110208289A1 (en) * 2010-02-25 2011-08-25 Endospan Ltd. Flexible Stent-Grafts
US20110224785A1 (en) 2010-03-10 2011-09-15 Hacohen Gil Prosthetic mitral valve with tissue anchors
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9918833B2 (en) 2010-09-01 2018-03-20 Medtronic Vascular Galway Prosthetic valve support structure
EP4119107A3 (en) 2010-09-10 2023-02-15 Boston Scientific Limited Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
US8696741B2 (en) 2010-12-23 2014-04-15 Maquet Cardiovascular Llc Woven prosthesis and method for manufacturing the same
US9526638B2 (en) 2011-02-03 2016-12-27 Endospan Ltd. Implantable medical devices constructed of shape memory material
ES2641902T3 (en) 2011-02-14 2017-11-14 Sorin Group Italia S.R.L. Sutureless anchoring device for cardiac valve prostheses
EP2486894B1 (en) 2011-02-14 2021-06-09 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
US9855046B2 (en) 2011-02-17 2018-01-02 Endospan Ltd. Vascular bands and delivery systems therefor
WO2012117395A1 (en) 2011-03-02 2012-09-07 Endospan Ltd. Reduced-strain extra- vascular ring for treating aortic aneurysm
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
EP2579811B1 (en) 2011-06-21 2016-03-16 Endospan Ltd Endovascular system with circumferentially-overlapping stent-grafts
US9254209B2 (en) 2011-07-07 2016-02-09 Endospan Ltd. Stent fixation with reduced plastic deformation
CA2835893C (en) 2011-07-12 2019-03-19 Boston Scientific Scimed, Inc. Coupling system for medical devices
BR112014002174B1 (en) 2011-07-29 2020-12-01 University Of Pittsburgh Of The Commonwealth System Of Higher Education heart valve structure, multi-membrane heart valve structure and method for making a heart valve structure
EP2739214B1 (en) 2011-08-05 2018-10-10 Cardiovalve Ltd Percutaneous mitral valve replacement and sealing
WO2013021374A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9668859B2 (en) 2011-08-05 2017-06-06 California Institute Of Technology Percutaneous heart valve delivery systems
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
CA3040390C (en) 2011-08-11 2022-03-15 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
WO2013030818A2 (en) * 2011-08-28 2013-03-07 Endospan Ltd. Stent-grafts with post-deployment variable axial and radial displacement
US9427339B2 (en) 2011-10-30 2016-08-30 Endospan Ltd. Triple-collar stent-graft
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
WO2013084235A2 (en) 2011-12-04 2013-06-13 Endospan Ltd. Branched stent-graft system
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
EP2609893B1 (en) 2011-12-29 2014-09-03 Sorin Group Italia S.r.l. A kit for implanting prosthetic vascular conduits
WO2013112547A1 (en) 2012-01-25 2013-08-01 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
US9770350B2 (en) 2012-05-15 2017-09-26 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US20130324906A1 (en) 2012-05-31 2013-12-05 Valen Tx, Inc. Devices and methods for gastrointestinal bypass
US9173759B2 (en) 2012-05-31 2015-11-03 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9681975B2 (en) 2012-05-31 2017-06-20 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9301835B2 (en) 2012-06-04 2016-04-05 Edwards Lifesciences Corporation Pre-assembled bioprosthetic valve and sealed conduit
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
JP6463265B2 (en) 2012-07-20 2019-01-30 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーCook Medical Technologies Llc Implantable medical device having a sleeve
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9585748B2 (en) 2012-09-25 2017-03-07 Edwards Lifesciences Corporation Methods for replacing a native heart valve and aorta with a prosthetic heart valve and conduit
US9844436B2 (en) 2012-10-26 2017-12-19 Edwards Lifesciences Corporation Aortic valve and conduit graft implant tool
US9681952B2 (en) 2013-01-24 2017-06-20 Mitraltech Ltd. Anchoring of prosthetic valve supports
EP2961349A1 (en) * 2013-02-28 2016-01-06 Boston Scientific Scimed, Inc. Stent with balloon for repair of anastomosis surgery leaks
US9744032B2 (en) * 2013-03-11 2017-08-29 Cook Medical Technologies Llc Endoluminal prosthesis comprising a valve and an axially extendable segment
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9757264B2 (en) 2013-03-13 2017-09-12 Valentx, Inc. Devices and methods for gastrointestinal bypass
US9744037B2 (en) 2013-03-15 2017-08-29 California Institute Of Technology Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
EP2991586A1 (en) 2013-05-03 2016-03-09 Medtronic Inc. Valve delivery tool
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
CA2914856C (en) 2013-06-25 2021-03-09 Chad Perrin Thrombus management and structural compliance features for prosthetic heart valves
CN105555231B (en) 2013-08-01 2018-02-09 坦迪尼控股股份有限公司 External membrane of heart anchor and method
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
CA2924389C (en) 2013-10-28 2021-11-09 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10603197B2 (en) 2013-11-19 2020-03-31 Endospan Ltd. Stent system with radial-expansion locking
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
CA2937566C (en) 2014-03-10 2023-09-05 Tendyne Holdings, Inc. Devices and methods for positioning and monitoring tether load for prosthetic mitral valve
WO2016016899A1 (en) * 2014-07-30 2016-02-04 Mitraltech Ltd. Articulatable prosthetic valve
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
BR112017012425A2 (en) 2014-12-18 2018-01-02 Endospan Ltd endovascular stent graft with fatigue resistant lateral tube
JP6826035B2 (en) 2015-01-07 2021-02-03 テンダイン ホールディングス,インコーポレイテッド Artificial mitral valve, and devices and methods for its delivery
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
WO2016125160A1 (en) 2015-02-05 2016-08-11 Mitraltech Ltd. Prosthetic valve with axially-sliding frames
JP6718459B2 (en) 2015-02-05 2020-07-08 テンダイン ホールディングス,インコーポレイテッド Expandable epicardial pad and device and methods of delivery thereof
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10119882B2 (en) 2015-03-10 2018-11-06 Edwards Lifesciences Corporation Surgical conduit leak testing
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
WO2016205773A1 (en) * 2015-06-18 2016-12-22 Peca Labs, Inc. Valved conduit and method for fabricating same
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
WO2017004377A1 (en) 2015-07-02 2017-01-05 Boston Scientific Scimed, Inc. Adjustable nosecone
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
CA2998576A1 (en) 2015-10-13 2017-04-20 Venarum Medical, Llc Implantable valve and method
AU2016362474B2 (en) 2015-12-03 2021-04-22 Tendyne Holdings, Inc. Frame features for prosthetic mitral valves
JP6795591B2 (en) 2015-12-28 2020-12-02 テンダイン ホールディングス,インコーポレイテッド Atrial pocket closure for artificial heart valve
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US11000370B2 (en) 2016-03-02 2021-05-11 Peca Labs, Inc. Expandable implantable conduit
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
WO2017218375A1 (en) 2016-06-13 2017-12-21 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
EP3478224B1 (en) 2016-06-30 2022-11-02 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus for delivery of same
EP3484411A1 (en) 2016-07-12 2019-05-22 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
US10098740B2 (en) * 2016-07-15 2018-10-16 Covidien Lp Venous valve prostheses
EP3848003A1 (en) 2016-08-10 2021-07-14 Cardiovalve Ltd. Prosthetic valve with concentric frames
US10610357B2 (en) 2016-10-10 2020-04-07 Peca Labs, Inc. Transcatheter stent and valve assembly
US11376121B2 (en) * 2016-11-04 2022-07-05 Highlife Sas Transcatheter valve prosthesis
US10456247B2 (en) 2016-11-04 2019-10-29 Highlife Sas Transcatheter valve prosthesis
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
WO2018226915A1 (en) 2017-06-08 2018-12-13 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
WO2019014473A1 (en) 2017-07-13 2019-01-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
EP3661458A1 (en) 2017-08-01 2020-06-10 Boston Scientific Scimed, Inc. Medical implant locking mechanism
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
CN111225633B (en) 2017-08-16 2022-05-31 波士顿科学国际有限公司 Replacement heart valve coaptation assembly
WO2019046099A1 (en) 2017-08-28 2019-03-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US11337802B2 (en) 2017-09-19 2022-05-24 Cardiovalve Ltd. Heart valve delivery systems and methods
CA3158944A1 (en) * 2017-10-31 2019-05-09 W.L. Gore & Associates, Inc. Valved conduit
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
JP7047106B2 (en) 2018-01-19 2022-04-04 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device delivery system with feedback loop
EP3740160A2 (en) 2018-01-19 2020-11-25 Boston Scientific Scimed Inc. Inductance mode deployment sensors for transcatheter valve system
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
WO2019165394A1 (en) 2018-02-26 2019-08-29 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
EP3790474A1 (en) * 2018-05-08 2021-03-17 W.L. Gore & Associates, Inc. Occluder devices
WO2019222367A1 (en) 2018-05-15 2019-11-21 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
WO2019224577A1 (en) 2018-05-23 2019-11-28 Sorin Group Italia S.R.L. A cardiac valve prosthesis
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
WO2020123486A1 (en) 2018-12-10 2020-06-18 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11678980B2 (en) 2020-08-19 2023-06-20 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470157A (en) * 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4666442A (en) * 1984-03-03 1987-05-19 Sorin Biomedica S.P.A. Cardiac valve prosthesis with valve flaps of biological tissue
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5545215A (en) * 1994-09-14 1996-08-13 Duran; Carlos G. External sigmoid valve complex frame and valved conduit supported by the same
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6126686A (en) * 1996-12-10 2000-10-03 Purdue Research Foundation Artificial vascular valves
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6299635B1 (en) * 1997-09-29 2001-10-09 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6312465B1 (en) * 1999-07-23 2001-11-06 Sulzer Carbomedics Inc. Heart valve prosthesis with a resiliently deformable retaining member
US20010039450A1 (en) * 1999-06-02 2001-11-08 Dusan Pavcnik Implantable vascular device
US6375679B1 (en) * 1997-07-18 2002-04-23 Advanced Medical Solutions Ltd. Prosthetic valve sinus
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6494909B2 (en) * 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US20030055492A1 (en) * 1999-08-20 2003-03-20 Shaolian Samuel M. Transluminally implantable venous valve
US20030153974A1 (en) * 2001-10-11 2003-08-14 Benjamin Spenser Implantable prosthetic valve
US20040102855A1 (en) * 2002-11-21 2004-05-27 Scimed Life Systems, Inc. Anti-reflux stent
US20050085900A1 (en) * 2003-07-31 2005-04-21 Case Brian C. Prosthetic valve for implantation in a body vessel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1255510T5 (en) * 2000-01-31 2009-12-21 Cook Biotech Inc Stent Valve Klapper

Patent Citations (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470157A (en) * 1981-04-27 1984-09-11 Love Jack W Tricuspid prosthetic tissue heart valve
US4666442A (en) * 1984-03-03 1987-05-19 Sorin Biomedica S.P.A. Cardiac valve prosthesis with valve flaps of biological tissue
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5545215A (en) * 1994-09-14 1996-08-13 Duran; Carlos G. External sigmoid valve complex frame and valved conduit supported by the same
US5667523A (en) * 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6126686A (en) * 1996-12-10 2000-10-03 Purdue Research Foundation Artificial vascular valves
US6375679B1 (en) * 1997-07-18 2002-04-23 Advanced Medical Solutions Ltd. Prosthetic valve sinus
US6231598B1 (en) * 1997-09-24 2001-05-15 Med Institute, Inc. Radially expandable stent
US6464720B2 (en) * 1997-09-24 2002-10-15 Cook Incorporated Radially expandable stent
US6299635B1 (en) * 1997-09-29 2001-10-09 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20010039450A1 (en) * 1999-06-02 2001-11-08 Dusan Pavcnik Implantable vascular device
US6312465B1 (en) * 1999-07-23 2001-11-06 Sulzer Carbomedics Inc. Heart valve prosthesis with a resiliently deformable retaining member
US20030055492A1 (en) * 1999-08-20 2003-03-20 Shaolian Samuel M. Transluminally implantable venous valve
US6494909B2 (en) * 2000-12-01 2002-12-17 Prodesco, Inc. Endovascular valve
US20030153974A1 (en) * 2001-10-11 2003-08-14 Benjamin Spenser Implantable prosthetic valve
US20040102855A1 (en) * 2002-11-21 2004-05-27 Scimed Life Systems, Inc. Anti-reflux stent
US20050085900A1 (en) * 2003-07-31 2005-04-21 Case Brian C. Prosthetic valve for implantation in a body vessel
US7686844B2 (en) * 2003-07-31 2010-03-30 Cook Incorporated Prosthetic valve for implantation in a body vessel

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090125098A1 (en) * 2007-11-09 2009-05-14 Cook Incorporated Aortic valve stent graft
US10105218B2 (en) 2007-11-09 2018-10-23 Cook Medical Technologies Llc Aortic valve stent graft
US11033384B2 (en) 2007-11-09 2021-06-15 Cook Medical Technologies Llc Aortic valve stent graft
US8715337B2 (en) * 2007-11-09 2014-05-06 Cook Medical Technologies Llc Aortic valve stent graft
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8449607B2 (en) 2007-12-18 2013-05-28 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US20110066237A1 (en) * 2007-12-18 2011-03-17 Matheny Robert G Prosthetic tissue valve
US8980296B2 (en) 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US20100233235A1 (en) * 2009-02-18 2010-09-16 Matheny Robert G Compositions and methods for preventing cardiac arrhythmia
US10695171B2 (en) 2010-11-05 2020-06-30 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11911270B2 (en) 2010-11-05 2024-02-27 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11602428B2 (en) 2010-11-05 2023-03-14 Cook Medical Technologies Llc Stent structures for use with valve replacements
US11554011B2 (en) 2010-11-05 2023-01-17 Cook Medical Technologies Llc Stent structures for use with valve replacements
US8696744B2 (en) 2011-05-27 2014-04-15 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US11406495B2 (en) 2013-02-11 2022-08-09 Cook Medical Technologies Llc Expandable support frame and medical device
WO2014133543A1 (en) * 2013-03-01 2014-09-04 Cormatrix Cardiovascular, Inc. Two-piece prosthetic valve
WO2015123607A3 (en) * 2014-02-13 2016-02-25 Valvexchange, Inc. Temporary sub-valvular check valve
US10143554B2 (en) * 2015-12-03 2018-12-04 Medtronic Vascular, Inc. Venous valve prostheses
US10973640B2 (en) 2015-12-03 2021-04-13 Medtronic Vascular, Inc. Venous valve prostheses
US20170156863A1 (en) * 2015-12-03 2017-06-08 Medtronic Vascular, Inc. Venous valve prostheses
US11684476B2 (en) 2015-12-03 2023-06-27 Medtronic Vascular, Inc. Venous valve prostheses

Also Published As

Publication number Publication date
WO2005011535A3 (en) 2006-03-16
US20050085900A1 (en) 2005-04-21
US7686844B2 (en) 2010-03-30
WO2005011535A2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
US7686844B2 (en) Prosthetic valve for implantation in a body vessel
US7955376B2 (en) Implantable medical device with constrained expansion
US8128686B2 (en) Branched vessel prosthesis
US6299637B1 (en) Transluminally implantable venous valve
AU2006218278B2 (en) Stent valves and uses of same
US7402171B2 (en) Prosthetic valve that permits retrograde flow
US7670366B2 (en) Intraluminal support device with graft
US6840957B2 (en) Implantable prosthetic valve
US8372140B2 (en) Implantable valve prosthesis with independent frame elements
US20080091261A1 (en) Implantable valve prosthesis
US20030055492A1 (en) Transluminally implantable venous valve
AU2012244361B2 (en) Stent valves and uses of same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION